Resideo generated $3 million of operating cash against $2.0 billion of revenue in the six months ended July 4. A year earlier, the same stretch produced $135 million. That is a lot of business for very little cash.
The surface reading is still reasonably tidy: revenue rose 2.0%, gross profit climbed 4.6%, and gross margin reached 30.0% from 29.3%. The complication is underneath it. Operating income fell 26.0% to $131 million, and operating cash flow dropped 97.8%.
The squeeze showed up in the company’s use of cash. Inventory increased 10.6% to $1.4 billion, faster than revenue, while capital spending rose 27.5% to $65 million. Cash on hand fell to $549 million from $753 million over the comparable periods.
Resideo attributed the operating-income decline to a collection of costs and volume pressures:
"The decrease was primarily driven by higher selling, general and administrative expenses of $8 million, lower sales volumes of $7 million, unfavorable price and mix shift of $5 million, higher restructuring expenses of $4 million, and higher research and development costs of $2 million."
Resideo, 10-Q, Aug. 12, 2026.
The list adds up to a business whose gross profit improved without enough of that improvement reaching operating income. Research and development rose to $48 million from $41 million, and the company does not disclose a single cause for the cash-flow collapse.
Debt adds another fixed claim to the picture. Resideo said the settlement of its Indemnification Agreement increased outstanding debt by approximately $1.2 billion and lifted interest expense by $43 million.
"The increase was driven by an approximately $1.2 billion increase in outstanding debt related to the settlement of the Indemnification Agreement, resulting in $43 million of higher interest expense."
Resideo, 10-Q, Aug. 12, 2026.
That debt adds to the company’s interest burden, but does not explain the entire cash story. Resideo finished the six months with more inventory, more capital spending, and less cash, while diluted shares also rose 3.4% to 154 million.
There are offsets in the same filing. Resideo cited favorable price and mix, foreign exchange, and higher sales volumes in parts of the business, along with a net $17 million benefit from lower manufacturing costs, supply-chain efficiencies, and tariff refunds. The two operating segments both grew, though ADI Global Distribution added only 0.7% and Products and Solutions grew 4.4%.
At the latest close, REZI was $24.25, essentially unchanged on Aug. 11, after a 32.5% decline over six months. The company’s annual record supplies a little context: revenue reached $7.5 billion in 2025, but operating margin was 8.1%, below the 10.2% recorded in 2018. The latest six-month report adds a more immediate question than the annual chart does.
Resideo’s next quarterly report will provide the next clean comparison for operating cash, inventory, capital spending, and debt-related interest expense. The unresolved tension is simple: sales and gross margin are improving, but cash generation is not.
Source: Resideo Technologies’ 10-Q filed Aug. 12, 2026.